TY - JOUR
T1 - Japanese guideline for occupational allergic diseases 2014
AU - Dobashi, Kunio
AU - Akiyama, Kazuo
AU - Usami, Atsushi
AU - Yokozeki, Hiroo
AU - Ikezawa, Zenro
AU - Tsurikisawa, Naomi
AU - Nakamura, Yoichi
AU - Sato, Kazuhiro
AU - Okumura, Jiro
AU - Dobashi, Kunio
AU - Akiyama, Kazuo
AU - Usami, Atsushi
AU - Ikezawa, Zenro
AU - Tsurikisawa, Naomi
AU - Nakamura, Yoichi
AU - Sato, Kazuhiro
AU - Okumura, Jiro
AU - Adachi, Mitsuru
AU - Matsunaga, Kayoko
AU - Naito, Kensei
AU - Nakazawa, Tsugio
AU - Ohta, Ken
AU - Okano, Mitsuhiro
AU - Takayama, Kaoru
AU - Tohda, Yuji
AU - Watanabe, Masanari
AU - Yamaguchi, Masao
N1 - Funding Information:
1Graduate School of Health Sciences, Gunma University, Gunma, 2National Hospital Organization, Sagamihara National Hospital, 5Department of Dermatology, Yokohama City University Hospital, 6Department of Allergy and Respirology, National Hospital Organization, Sagamihara National Hospital, 7Medical Center for Allergic and Immune Diseases, Yokohama City Minato Red Cross Hospital, Kanagawa, 3Tohkai Research Institute for Pollinosis, Shi-zuoka, 4Department of Dermatology, Tokyo Medical and Dental University, Tokyo, 8Department of Environmental Health, Faculty of Medical Sciences, University of Fukui, Fukui, 9Department of Environmental Medicine and Behavioural Science, Kinki University School of Medicine, Osaka, Japan and 10Members listed at the end of the article. Conflict of interest: KA received honoraria from GlaxoSmithKline, MSD, and research funding from Astellas Pharma. MA received honoraria from GlaxoSmithKline, Novartis Pharma, Astellas Pharma, Kyorin Pharmaceutical. KO received honoraria from GlaxoSmithKline, Kyorin Pharmaceutical, AstraZeneca, Boehringer Ingelheim, and research funding from MSD. MO received honoraria from MSD, GlaxoSmithKline, Sanofi, Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma. YT received Kyorin Pharmaceutical, MSD, AstraZeneca. KN received honoraria from Mit-subishi Tanabe Pharma. The rest of the authors have no conflict of interest. Correspondence: Kunio Dobashi, Graduate School of Health Sciences, Gunma University, 3−39−22 Showa-machi, Maebashi, Gunma 371−8511, Japan. Email: dobashik@gunma−u.ac.jp Received 24 March 2014. 2014 Japanese Society of Allergology
Publisher Copyright:
© 2014 Japanese Society of Allergology.
PY - 2014/9/11
Y1 - 2014/9/11
N2 - In 2013, a guideline for occupational allergic diseases was published for the first time in Japan. Occupational allergic diseases are likely to worsen or become intractable as a result of continuous exposure to high concentrations of causative antigens, and are socioeconomically important diseases with which the patients might sometimes lose jobs due to work interruptions. Guidelines for occupational allergic diseases have been published in many countries. This guideline consists of six chapters about occupational asthma, occupational allergic rhinitis, occupational skin diseases, hypersensitivity pneumonitis and occupational anaphylaxis shock, and legal aspects of these diseases. The guideline is characterized with the following basic structure: Clinical Questions (CQs) are set with reference to Minds (Medical Information Network Distribution Service), statements by the committee are correspondingly listed, recommended grades and evidence levels are defined, and then descriptions and references are indicated.
AB - In 2013, a guideline for occupational allergic diseases was published for the first time in Japan. Occupational allergic diseases are likely to worsen or become intractable as a result of continuous exposure to high concentrations of causative antigens, and are socioeconomically important diseases with which the patients might sometimes lose jobs due to work interruptions. Guidelines for occupational allergic diseases have been published in many countries. This guideline consists of six chapters about occupational asthma, occupational allergic rhinitis, occupational skin diseases, hypersensitivity pneumonitis and occupational anaphylaxis shock, and legal aspects of these diseases. The guideline is characterized with the following basic structure: Clinical Questions (CQs) are set with reference to Minds (Medical Information Network Distribution Service), statements by the committee are correspondingly listed, recommended grades and evidence levels are defined, and then descriptions and references are indicated.
KW - Hypersensitivity pneumonitis
KW - Occupational allergic rhinitis
KW - Occupational anaphylaxis
KW - Occupational asthma
KW - Occupational skin diseases
UR - http://www.scopus.com/inward/record.url?scp=84907506100&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907506100&partnerID=8YFLogxK
U2 - 10.2332/allergolint.14-RAI-0771
DO - 10.2332/allergolint.14-RAI-0771
M3 - Review article
AN - SCOPUS:84907506100
SN - 1323-8930
VL - 63
SP - 421
EP - 442
JO - Allergology International
JF - Allergology International
IS - 3
ER -